Clinical trials for cancer control and treatment typically have very few patients from non-White backgrounds, but a multipronged approached has increased participation of underrepresented patients.
The Alliance for Clinical Trials in Oncology, in partnership with the National Cancer Institute, part of the National Institutes of Health, today announced the opening of a new study for participant enrollment that aims to obtain a reference set of blood samples from newly diagnosed patients with cancer and healthy individuals without cancer to include in a future study to assess the utility of early cancer detection blood tests.